Radar › Companies › Life Sciences · Hesse
Radar · Life Sciences in Hesse

Best Life Sciences Companies in Hesse, Germany

The 37 best Life Sciences companies in Hesse, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Heidelberg Pharma.

37companies tracked
$29.2Mdisclosed funding
0unicorns
9have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × HESSE

Our analysis of 50 Life Sciences companies

$3.3b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.

50companies analysed
51%cloud-native stacks
2024funding peak (by rounds)
2016median founding year
40median Fliar Index™

Ranked: Best Life Sciences companies in Hesse

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1Heidelberg Pharma
Provider of preclinical services specializing in ADCs (Antibody Drug Conjugates)
$20M77 mo agoPublicAndreas Pahl
CEO & Sprecher des Vorstands at Heidelberg Pharma AG
1999JoomlaPHPUIKit+4422 patents
Targeted antibody‑drug conjugates using amatoxin payloads and cleavable linkers for cancer therapy
—
2Genome Biologics
Developer of therapies for cardiovascular and cardiometabolic diseases
$3M60 mo agoFunding RaisedJonathan Ward
Co-Founder
2016—23 patents
Human cardiac organoid and tissue-mimetic platforms for disease modeling and drug screening
—
3Biologs
Provider of genetic information management tool
$3M128 mo agoFunding Raised—2013———
4GenXPro
Developer of molecular biology reagents and bioinformatics solutions
$2M80 mo agoFunding RaisedRalf Horres
Co-Founder
2005WordPressMySQLPHP+168 patents
Patents concentrated in chemistry & materials
—
5Zedira
Provider of protein related products for biotech research and development application
$705K117 mo agoSeries B—2007Cart FunctionalityPHPNginx+3160 patents
Therapeutic inhibitors of transglutaminase enzymes and coagulation factor XIII for disease treatment
—
6Phialogics
Developer of cell therapies for the treatment of auto-immune diseases
$657K40 mo agoSeedAndreas Knethen
Co-Founder
2021———
7NanoScale Systems
Developer of sensors and 3D nanoprinting technology for medical applications
$437K46 mo agoFunding RaisedAlexander Kaya
Founder & CEO
2005———
8CLADE
Developer of MIR spectroscopy for thr life science industry
$10K111 mo agoFunding RaisedJochen Hirsch
Co-CEO
2001WordPress Block EditorElementorWordPress+18——

Top 12 Life Sciences companies in Hesse

#1
Seed · Frankfurt Am Main, Hesse · founded 2021 · 5 employees
$657.4Kraised
▾

Developer of cell therapies for the treatment of auto-immune diseases. The company is developing cell-type-specific immune checkpoint activators by using protein engineering of receptor ligands to generate signaling agonists that modulate the activity of immune cells.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 959 LinkedIn followers — 4.3% of this cohort's audience · 40 engagements/post (2.0× cohort median)
Activity: 2 awards announced in 12 mo
Funding rounds
  • Apr 2023Seed$657.4K
Founders & team
Andreas KnethenCo-FounderPascal OromiCo-Founder & Chief Business OfficerAndreas WeigertCo-Founder
Investors
HTGF, BioVaria, BaseLaunch
#2
Public · Frankfurt Am Main, Hesse · founded 1999 · 113 employees
$20Mraised
▾

Heidelberg Pharma (a wholly owned subsidiary of Wilex, a Munich based public biopharma company) is a preclinical CRO and also a drug development company with a proprietary ADC technology. The company's ADC technology is based on the RNA-polymerase II inhibitor Amanitin, isolated from the Green Deathcap mushroom. Amanitin is conjugated with antibodies binding at low-copy-number antigens and the company claims that it has demonstrated outstanding activity of amanitin-based ADCs in therapy-resistant tumour cells, along with its partners. The tolerability and therapeutic window have been determined in rodent and non-human primate models. The company has also developed linkers for Amanitin based ADCs. Heidelberg Pharma's preclinical development services cater mainly to developers of anti-cancer and anti-inflammatory drugs. Their capabilities include in vivo pharmacology, DMPK, bioanalytics, molecular biology, and chemistry studies.

Funding rounds
  • Apr 2020Grant (prize money)$540K
  • Jan 2020Post IPO$16.6M
  • Nov 2019Grant (prize money)$297.1K
  • Nov 2018Grant (prize money)$288.2K
Founders & team
Andreas PahlCEO & Sprecher des Vorstands at Heidelberg Pharma AG
Investors
Dievini, Bmbf, Europa
Tech stack
Apache Http ServerAwesompleteHstsJoomlaMatomo AnalyticsPersonio
#3
Funding Raised · Frankfurt Am Main, Hesse · founded 2016 · 12 employees
$3Mraised
▾

Developer of therapies for cardiovascular and cardiometabolic diseases. The company focuses on therapeutic target and drug discovery for illnesses lacking effective treatments. It employs technology platforms to accelerate therapy development, specifically in cardiotoxicity, heart failure, and hypertrophic cardiomyopathy. Strategies involve cellular metabolic modulation and cardiac regeneration reactivation. The company utilizes Ai-driven data analysis and preclinical organoid models for therapeutic validation.

Funding rounds
  • Aug 2021Grant (prize money)$59K
  • Sep 2018Grant (prize money)$2.8M
  • Sep 2017Grant (prize money)$59K
  • Jun 2017Grant (prize money)$56.1K
Founders & team
Jonathan WardCo-Founder
Investors
Europa, EIC Fund, JLABS, CARMA FUND
Tech stack
Godaddy Website BuilderPwaOpen Graph
#4
Funding Raised · Darmstadt, Hesse · founded 2005 · 4 employees
$437.4Kraised
▾

Developer of sensors and 3D nanoprinting technology for medical applications. The company provides solutions for medical implants, catheters, and point-of-care diagnostics. It offers sensors for force, pressure, displacement, and strain measurements. The company's technology is used in biotechnology, life science, and general analytics.

Funding rounds
  • Nov 2022Grant (prize money)$103.6K
  • Dec 2016Grant (prize money)—
  • Oct 2013Grant (prize money)$333.8K
Founders & team
Alexander KayaFounder & CEO
Investors
Europa
Tech stack
WordpressMysqlPhpEmbedplusApache Http ServerJquery Migrate
#5
Funding Raised · Frankfurt Am Main, Hesse · founded 2005
$1.8Mraised
▾

Developer of molecular biology reagents and bioinformatics solutions. The company offerings include kits and reagents for RNA-Seq, miRNA, MACE, small RNA-Seq, Methyl-Seq, ChIPSeq, and many others.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 802 LinkedIn followers — 3.6% of this cohort's audience
Funding rounds
  • Jan 2020Grant (prize money)$497.8K
  • Sep 2015Grant (prize money)$295.1K
  • Mar 2015Grant (prize money)$349K
  • Jan 2015Grant (prize money)$295.1K
Founders & team
Ralf HorresCo-FounderPeter WinterCEO
Investors
Europa
Tech stack
All In One SeoApache Http ServerContact Form 7Cookie NoticeGoogle AnalyticsGoogle Font Api
#6
Funding Raised · Frankfurt Am Main, Hesse · founded 2013 · 7 employees
$2.6Mraised
▾

Provider of genetic information management tool. The management system performs the following functions of translation of genetic test results into clinically actionable information, efficient production of consistent diagnostic reports, and delivery of test results and clinical information in a comprehensible way. The system has three modules diagnostic report module, knowledge management module, and delivery module.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 422 LinkedIn followers
Funding rounds
  • Jan 2016Grant (prize money)$2.5M
  • Jan 2015Grant (prize money)$87.6K
Investors
Europa
#7
Series B · Darmstadt, Hesse · founded 2007 · 15 employees
$705.1Kraised
▾

Zedira is a reagents company that developed and produces transglutaminases and protein-related products for research applications. Its portfolio includes transglutaminases, microbial transglutaminase, inhibitors, proteases, protein labeling reagents, blood coagulation reagents, cereal proteins, assays and substrates, and antibodies and protein microarrays.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 876 LinkedIn followers — 3.9% of this cohort's audience
Funding rounds
  • Nov 2016Grant (prize money)$1.6M
  • Feb 2015Grant (prize money)—
  • May 2010Series B—
  • Feb 2009Grant (prize money)$962.8K
Investors
HTGF, Bmbf, R-Biopharm
Tech stack
Cart FunctionalityJqueryMatomo AnalyticsMicrosoft 365NginxPhp
#8
Funding Raised · Frankfurt Am Main, Hesse · founded 2001
$10.1Kraised
▾

Developer of MIR spectroscopy for the life science industry. The flagship product of the company is "Mira" a Mid Infrared (MIR) spectroscopy solution that uses AquaSpec technology for rapid analysis, identification, and evaluation of chemometrics using standardized chemical and physical methodologies.

Funding rounds
  • Jun 2017Grant (prize money)$10.1K
Founders & team
Jochen HirschCo-CEORainer ‍ MarquartCo-CEO
Investors
Europa, German Accelerator
Tech stack
Contact Form 7Core-JsElementorElementor Header & Footer BuilderHubspotJquery
#9
Funding Raised · Frankfurt Am Main, Hesse · founded 1895 · 150 employees
—raised
▾

Oculus develops a range of eye diagnostic equipment for the oncological market. The company has eight subsidiaries in Europe, Asia, and America. The company has developed products such as the Pentacam (anterior segment analysis), manual refraction, binocular loupes, Perimetry systems, Refraction equipment, Keratograph and Easyfield Topography systems, etc. The company also provides training and educational resources, which are accessible 24/7 in its online library or offline during many in house training sessions throughout the year. The company also offers Vitreoretinal Surgery equipment such as BIOM range, ImproVue, and SDI.

Investors
Europa
Tech stack
Apache Http ServerBootstrapCloudflareGsapHstsJquery
#10
Seed · Darmstadt, Hesse · founded 2014
—raised
▾

Cooling box for last mile transport of medicines and samples

Founders & team
Martin VoigtFounder & CEOIna BrecheisCo-FounderJulian PothsCo-Founder
Investors
EIT Climate-KIC, UNCAP, Goethe Unibator
Tech stack
WordpressMysqlPhpZurb FoundationWpbakeryWp Rocket
#11
Acquired · Frankfurt Am Main, Hesse · founded 1962 · 94 employees
—raised
▾

Manufacturer of dental appliances and technology catering to dental technicians, dentists and implantologists. The company specializes in the provision of CAD/CAM technology, implants and implant navigation software, temporomandibular joint analysis and dental acrylic and alloy materials.

Founders & team
Wolf ZientzCEO
Investors
bayernlb-cp.de
Tech stack
Apache Http ServerBabelBootstrapCart FunctionalityCloudflareCloudflare Bot Management
#12
Seed · Frankfurt Am Main, Hesse · founded 2006 · 2 employees
—raised
▾

Developer of cell-based regenerative therapy to treat cardiovascular diseases. The company isolates BMCs from bone marrow aspirate, which it injects directly into the coronary arteries or peripheral arteries. The therapies are used in myocardial infarction, chronic heart disease, dilated cardiomyopathy, and peripheral artery disease.

Funding rounds
  • Jul 2006Seed—
Founders & team
Manfred RuedigerCEO
Investors
Entrepreneurs Fund, Kfw

Funding & investor landscape

$29.2Mtotal disclosed funding
8companies funded
27disclosed rounds
0rounds last 90 days
Most active investors
Europa7 rounds
Bmbf2 rounds
HTGF2 rounds
Mercurius Private Equity2 rounds
BaseLaunch1 rounds
BioVaria1 rounds
CARMA FUND1 rounds
CoStone Capital1 rounds
Dievini1 rounds
EIC Fund1 rounds

Notable founders

Andreas Knethen
Co-Founder · Phialogics
Pascal Oromi
Co-Founder & Chief Business Officer · Phialogics
Andreas Pahl
CEO & Sprecher des Vorstands at Heidelberg Pharma AG · Heidelberg Pharma
Jonathan Ward
Co-Founder · Genome Biologics
Alexander Kaya
Founder & CEO · NanoScale Systems
Ralf Horres
Co-Founder · GenXPro
Peter Winter
CEO · GenXPro
Jochen Hirsch
Co-CEO · CLADE
Rainer ‍ Marquart
Co-CEO · CLADE
Martin Voigt
Founder & CEO · Nelumbox
Ina Brecheis
Co-Founder · Nelumbox
Wolf Zientz
CEO · Schutz Dental
Prism market signals · Germany · country-scoped Prism corpus, 141,341 docs

Market landscape — 10 sub-themes by coverage

Share of Life Sciences coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH SIGNALS · Germany

How research on Biotechnology is moving in Germany

A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,297 Germany-affiliated papers.

research sentiment over time
200820152026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and intensifying — the enthusiastic (strongly-positive) share moved 38% → 41% across 2008–2026.
top research entities
  • Heidelberg University85
  • German Cancer Research Center49
  • Ludwig-Maximilians-Universität München48
  • Technical University of Munich43
  • Karlsruhe Institute of Technology33
leading researchers
Lennart Hilbert · Henry Reyer · Michael Oster · Nares Trakooljul · Badhe, Pravin · Avon Augustin Nalpadan · Siriluck Ponsuksili · Ralf Nauen
▲ Breakthroughs421 · 32%
▼ 35%→31% share
▼0.9× share momentum0 median citations78% since 2021mostly empirical
Breakthroughs are cooling (35%→31% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene3→29
  • Mutant3→19
  • Transcription (linguistics)3→16
  • Messenger RNA1→14
  • Immune system1→12
Newly emergingGenome 0→15 · Mutation 0→13 · RNA polymerase II 0→9
Landmark The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets · 4,863 cites
◆ Advancements429 · 33%
33%→33% share
▲1.0× share momentum0 median citations82% since 2021mostly empirical
Advancements are cooling (33%→33% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene3→20
  • Agriculture2→12
  • Extracellular1→11
  • Immune system1→11
  • Transcriptome1→9
Newly emergingDownregulation and upregulation 0→12 · Selection (genetic algorithm) 0→11 · Antibody 0→10
Landmark Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klot · 5,606 cites
▼ Concerns184 · 14%
▼ 17%→14% share
▼0.8× share momentum0 median citations79% since 2021mostly empirical
Concerns are cooling (17%→14% of field), led by Antibiotic resistance.
rising sub-themes (early→recent)
  • Antibiotic resistance2→9
  • Gene1→7
  • Agriculture4→9
  • Antimicrobial1→4
  • Microbiome1→4
Newly emergingContext (archaeology) 0→11 · Sustainability 0→9 · Production (economics) 0→7
Landmark Prebiotic effects: metabolic and health benefits · 2,037 cites
RESEARCH HOTSPOTS · Germany

Where biotechnology is researched across Germany

Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.

Munich119 · +0.49
Hot · In vivoAdvancing · Messenger RNAOpportunity · In vitroConcern · Broiler
Berlin91 · +0.38
Hot · T cellAdvancing · Cytotoxic T cellOpportunity · In vitroConcern · Production (economics)
Heidelberg90 · +0.52
Hot · GliomaAdvancing · Cancer researchOpportunity · Gene
Jülich/Bonn72 · +0.41
Hot · Innate immune systemAdvancing · AntimicrobialOpportunity · Interferon
Karlsruhe34 · +0.30
Hot · PolymeraseAdvancing · GenomicsOpportunity · Zebrafish
Aachen23 · +0.51
Hot · Flow cytometryOpportunity · Cell culture
Dresden22 · +0.54
Opportunity · Cell culture
Stuttgart7 · +0.56
Opportunity · DNA methylation
PATENT SIGNAL · Germany

Who's filing biotechnology patents in Germany

Germany biotechnology patent filing is cooling — 53,233 filings from 8,000 assignees (2016–2025), led by Immatics Biotechnologies, BASF Plant Science, BASF SE; annual filings 4819→4267.

53,233 filings8,000 assigneespeak 6040/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
  • Immatics Biotechnologies4872
  • BASF Plant Science3982
  • BASF SE3543
  • Boehringer Ingelheim INT3438
  • Merck Patent3133
  • MAX Planck Gesellschaft1799
  • Evonik Degussa1680
  • Amgen RES Munich1665

Common questions

How many Life Sciences companies are there in Hesse, Germany?
Radar tracks 37 indexable Life Sciences companies headquartered in Hesse, Germany that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Hesse, Germany?
The Life Sciences companies in Hesse, Germany on this list have raised a combined $29.2M in disclosed equity funding across 8 funded companies.
Which is the highest-funded Life Sciences company in Hesse, Germany?
Heidelberg Pharma is the highest-funded Life Sciences company in Hesse, Germany, with $20M in disclosed equity funding.
How many Life Sciences companies in Hesse, Germany are funded?
8 of the 37 Life Sciences companies in Hesse, Germany on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Hesse, Germany?
None of the Life Sciences companies in Hesse, Germany on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Hesse, Germany Life Sciences companies?
The most active investors in Hesse, Germany Life Sciences companies on this list include Europa, Bmbf, HTGF, Mercurius Private Equity, BaseLaunch.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon